MERLI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 168
EU - Europa 101
AS - Asia 42
AF - Africa 8
OC - Oceania 1
Totale 320
Nazione #
US - Stati Uniti d'America 168
GB - Regno Unito 33
SE - Svezia 31
CN - Cina 17
SG - Singapore 16
DE - Germania 9
IE - Irlanda 6
IT - Italia 6
IN - India 5
FR - Francia 4
RU - Federazione Russa 4
ZA - Sudafrica 4
EE - Estonia 3
TG - Togo 3
BE - Belgio 2
JO - Giordania 2
AU - Australia 1
CI - Costa d'Avorio 1
FI - Finlandia 1
GR - Grecia 1
ID - Indonesia 1
NL - Olanda 1
VN - Vietnam 1
Totale 320
Città #
Southend 30
Houston 25
Fairfield 20
Ann Arbor 17
Singapore 16
Chandler 13
Ashburn 12
Seattle 10
Santa Clara 9
Cambridge 7
Woodbridge 7
Dublin 6
Princeton 6
Wilmington 6
Boardman 5
Lomé 3
Nanjing 3
Padova 3
Redmond 3
Westminster 3
Amman 2
Berlin 2
Brussels 2
Jiaxing 2
Mountain View 2
Shenyang 2
Zhengzhou 2
Abidjan 1
Beijing 1
Bremen 1
Bühl 1
Canberra 1
Changsha 1
Den Haag 1
Hangzhou 1
Hanoi 1
Helsinki 1
Jakarta 1
Muizenberg 1
Saint Petersburg 1
Shenzhen 1
Tianjin 1
Turin 1
Totale 234
Nome #
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma 116
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma 113
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program 101
Totale 330
Categoria #
all - tutte 832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202084 0 0 0 0 12 23 11 12 13 4 5 4
2020/202133 7 3 2 0 2 2 1 0 6 1 3 6
2021/202254 3 1 4 10 5 6 0 6 2 0 10 7
2022/202365 4 9 3 8 6 8 3 3 15 2 1 3
2023/202410 0 4 0 1 2 0 2 1 0 0 0 0
2024/202537 2 12 5 4 14 0 0 0 0 0 0 0
Totale 330